Compare Novavax Inc (NVAX) vs Nasdaq100 ETF (QQQ) Price & Performance

Novavax IncTrade

Nasdaq100 ETFTrade

Price performance (Past 24H)

Key statistics

Novavax Inc vs Nasdaq100 ETF — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Nasdaq100 ETF trades at $708.04. The key difference: Nasdaq100 ETF is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.

	NVAX	QQQ
Market Cap	$1.30B	—
Sector	Health	—
52-Week High	$11.19	$746.16
52-Week Low	$6.22	$553.88
Enterprise Value	$800.50M	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novavax Inc

Novavax (NVAX) trades at $8.08, down 1.64% on the day, with a bearish technical signal but strong recent earnings beats. The company reported $1.12B revenue in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Analyst consensus is bullish with a $14.00 price target, but negative shareholder equity and cash flow concerns persist.

Outlook remains mixed: strong valuation ratios and analyst support suggest upside potential, but negative cash flows, high liabilities, and projected 2026 losses pose significant risks. Investor sentiment is cautious amid recent stock declines and shareholder dissent highlighted in recent news.

Nasdaq100 ETF

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVAX

View details →

QQQ

iShares Nasdaq Top 30 ETF outperforms QQQ with a 30% return by focusing on mega-cap tech giants.24/7 Wall Street · 2 days agoBullish REX AI Equity Premium Income ETF offers 36.5% yield but caps upside and may return capital.24/7 Wall Street · 3 days agoNeutral Invesco's IQQQ ETF offers more Nasdaq upside than typical covered-call funds with daily call resets.24/7 Wall Street · 4 days agoNeutral View details →

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

About Nasdaq100 ETF

The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.